In February 2023, RPV conducted a survey of 2,036 patients and family caregivers (loved ones helping with care) in the United States. The study questions pertained to preferences regarding direct-to-consumer television advertising of treatments and medications. The findings were presented and discussed at the Xpectives Health Summit's DTC National track on April 20, 2023 in Boston, MA, by Pam Cusick, Senior Vice President of Rare Patient Voice.
Click below to access the study report as presented at the conference.
